The most elaborately studied chemokines in atherosclerosis, CCL2/MCP-1 and CCL5/RANTES, have been implied to reflect the burden of atherosclerotic lesions in cardiovascular disease patients [30], [32]. Here, CCL5 is linked to cardiovascular disorder.